EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, GOSS: Gossamer Bio Inc

12 Dec 25 15:59
LAST:

3.605

CHANGE:
 0.02		OPEN:
3.720		HIGH:
3.790		ASK:
0.000		VOLUME:
2.89M
CHG(%):
0.55		PREV:
3.620		LOW:
3.560		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
12 Dec 253.7203.7903.5603.6003.48M
11 Dec 253.5003.8003.4703.6204.29M
10 Dec 253.4803.5283.3403.4903.05M
09 Dec 253.4503.5403.4303.4501.65M
08 Dec 253.3503.4603.3503.4101.84M
05 Dec 253.3503.4003.2453.3302.22M
04 Dec 253.4103.4303.3003.3202.19M
03 Dec 253.0403.4503.0103.4204.71M
02 Dec 253.1403.1502.9752.9903.67M
01 Dec 253.2703.3053.1053.1403.6M

PROFILE

Name:Gossamer Bio Inc
About:Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
Sector:Healthcare
Industry:Biotechnology
Address:3115 Merryfield Row, San Diego, CA, United States, 92121
Website:https://www.gossamerbio.com
CUSIP:38341P102
CIK:0001728117
ISIN:US38341P1021
FIGI:BBG00MVWLLM2
LEI:549300ZOC0N2W6PSFR58

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-9.56 
Forward P/E:-3.55 
PEG Ratio:0.05 
Price to Sales:13.94 
Price to Book:-11.78 
Operating Margin:-3.37 
Return on Assets:-0.30 
Return on Equity:-7.83 
EPS Ratio:-0.61 
Revenue:40.24M 
Shares:228.88M 
Market Cap:825.11M 

TECHNICAL INDICATORS

MA5:3.512.6%
MA10:3.386.8%
MA20:3.2511.0%
MA50:2.7331.9%
MA100:2.5939.2%
MA200:1.8990.7%
STO9:75.31
STO14:75.31
RSI14:68.24 
WPR14:-3.17 
MTM14:0.42
ROC14:0.13 
ATR:0.20 
Week High:3.805.4%
Week Low:3.2511.1%
Month High:3.805.4%
Month Low:2.4290.7%
Year High:3.805.4%
Year Low:0.76374.3%